Adverse events after oral vaccination against cholera with CVD103-HgR

Wiener Klinische Wochenschrift

Volumn 110, Issue 10, 1998, Pages 376-378

  Wiedermann, Gerhard ^a   Kollaritsch, Herwig ^a   Jeschko, Eva ^a   Kundi, Michael ^a   Herzog, Christian ^b   Wegmüller, Bernhard ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Berna Biotech AG   (Switzerland)

Author keywords

Oral cholera vaccination; Safety of oral cholera vaccination in travellers, CVD103 HgR vaccine.; Side effects and tolerability of Orochol

Indexed keywords

CHOLERA VACCINE;

ARTICLE; CHOLERA; DIARRHEA; DRUG EFFECT; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; TRAVEL; VACCINATION; VOMITING;

EID: 0032557675     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Anonymous (1996) Cholera in 1995. Weekly Epidemiol Rec 71: 157-163
2. Anonymous (1992) Guidelines for cholera control - revised 1992. WHO/CDD/SER/80. 4 Rev 4 World Health Organisation, 1211 Geneva 27, Switzerland
3. Barret P, Clarke P, Cryz SJ (1993) Oral cholera vaccine well tolerated. Br Med J 307: 1423
4. Cryz SJ, Levine MM, Kaper JB, Fürer E, Althaus B (1990) Randomised double-blind placebo-controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD103-HgR in Swiss adults. Vaccine 8: 577-580
5. Kollaritsch H, Furer E, Herzog C, Wiedermann G, Que JU, Cryz SJ (1996) Randomised, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella Typhi Ty21a and Vibrio cholerae CVD103-HgR live oral vaccines. Infect Immun 64: 1454-1457
6. Levine MM, Herrington D, Losonsky G, Tall B, Kaper JB, Ketley J, Tacket CO, Cryz SJ (1988) Safety, immunogenicity and efficacy of recombinant live oral cholera vaccines. CVD103 and CVD103-HgR. Lancet ii: 647-670
7. Levine MM, Kaper J, Herrington D, Ketley J, Losonsky G, Tacket CO, et al (1988) Safety, immunogenicity and efficacy of recombinant live oral cholera vaccines, CVD103 and CVD103-HgR. Lancet ii: 467-470
8. Levine MM, Kaper JB (1993) Live oral vaccines against cholera: an update. Vaccine 11: 207-212
9. Simanjuntak CH, O'Hanley P, Punjabi NH et al (1993) Safety, immunogenicity and transmissibility of single dose CVD103HgR in 24-to 50-month old Indonesian children. J Infect Dis 168: 1169-1176
10. Tacket CO, Losonsky G, Nataro JP, Cryz SJ, Edelman R, Kaper JB, Levine MM (1992) Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD103-HgR. J Infect Dis 166: 837-841